Invitation to media and analyst briefing for BioGaia Q4 2023 report

BioGaia's (NASDAQ: BIOG) financial report for the fourth quarter of 2023 will be published at approximately 8:00 AM CET on February 7, 2024.

The company will issue a press release with the complete financial report attached, including tables. Following publication of the press release, the financial report will be available on BioGaia´s website.

CEO Theresa Agnew and CFO Alexander Kotsinas will comment on the report and take questions at a live audiocast at 9:30 AM CET.

To join the audiocast with teleconference and ask a question, please click here: https://financialhearings.com/event/48493
 

Follow us:
Subscribe to BioGaia press releases here
LinkedIn here

Contacts:
Alexander Kotsinas, CFO
Email alexander.kotsinas@biogaia.com
Phone +46 735 00 11 11

Mikaela Idermark Stern, Corporate Communications
Email mikaela.idermark.stern@biogaia.com
Phone +46 730 95 61 50

About BioGaia
BioGaia is an innovative Swedish healthcare company that develops, markets, and sells probiotic products with documented health benefits. The products are sold through local distribution partners or via own distribution in over 100 markets. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. biogaiagroup.com

Tags: